Ignite Creation Date:
2025-12-24 @ 10:34 PM
Ignite Modification Date:
2025-12-29 @ 10:26 PM
Study NCT ID:
NCT04882735
Status:
WITHDRAWN
Last Update Posted:
2024-09-19
First Post:
2021-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Acoramidis (AG10) in Subjects with Transthyretin Amyloid Polyneurophathy (ATTRibute-PN)
Sponsor:
Eidos Therapeutics, a BridgeBio company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-08
Start Date Type:
ACTUAL
Primary Completion Date:
2026-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-29
First Submit QC Date:
None
Study First Post Date:
2021-05-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-10
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL